Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Soft-Tissue Sarcomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02113826
What this trial is testing

Pazopanib for Metastatic Alveolar Soft Part Sarcoma

Who this might be right for
Metastatic Alveolar Soft Part Sarcoma
Seoul National University Hospital 6
Early research (Phase 1)Study completedNCT01169584
What this trial is testing

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

Who this might be right for
NeuroblastomaRhabdomyosarcomaLymphoma+2 more
Jennerex Biotherapeutics 6
Testing effectiveness (Phase 2)Study completedNCT00148109
What this trial is testing

Trial of Cetuximab in Patients With Metastatic and/or Locally Advanced Soft Tissue and Bony Sarcomas

Who this might be right for
Sarcoma
University of Michigan Rogel Cancer Center 36
Not applicableStudy completedNCT03022448
What this trial is testing

Geriatric Assessmen of Elderly "Unsuited" Patients Receiving Trabectedin in First Line Treatment For Advanced Soft Tissue Sarcomas (STS)

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
GWT-TUD GmbH 72
Testing effectiveness (Phase 2)Study completedNCT00874874
What this trial is testing

Sorafenib in Treating Patients With Angiosarcoma That is Locally Advanced, Metastatic, or Unable to Be Removed by Surgery

Who this might be right for
Sarcoma
Centre Oscar Lambret 88
Testing effectiveness (Phase 2)Ended earlyNCT02581384
What this trial is testing

Stereotactic Body Radiotherapy (SBRT) for Pulmonary Metastases in Ewing Sarcoma, Rhabdomyosarcoma, and Wilms Tumors

Who this might be right for
Ewing SarcomaRhabdomyosarcomaWilms Tumor+8 more
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT01653028
What this trial is testing

Alisertib in Treating Patients With Advanced or Metastatic Sarcoma

Who this might be right for
MyxofibrosarcomaRecurrent Adult Soft Tissue SarcomaRecurrent Leiomyosarcoma+5 more
National Cancer Institute (NCI) 72
Testing effectiveness (Phase 2)Ended earlyNCT02441309
What this trial is testing

A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)

Who this might be right for
Osteosarcoma
University of Oxford 8
Large-scale testing (Phase 3)WithdrawnNCT03773510
What this trial is testing

Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With Trabectedin

Who this might be right for
LeiomyosarcomaLiposarcomaSynovial Sarcoma
Italian Sarcoma Group
Testing effectiveness (Phase 2)Study completedNCT02470091
What this trial is testing

Denosumab in Treating Patients With Recurrent or Refractory Osteosarcoma

Who this might be right for
Metastatic OsteosarcomaRecurrent OsteosarcomaRefractory Osteosarcoma+3 more
Children's Oncology Group 56
Large-scale testing (Phase 3)UnknownNCT04757337
What this trial is testing

Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
UNICANCER 214
Testing effectiveness (Phase 2)Active Not RecruitingNCT05180695
What this trial is testing

HDM201 and Pazopanib in Patients With P53 Wild-type Advanced/Metastatic Soft Tissue Sarcomas

Who this might be right for
Advanced Soft-tissue SarcomaMetastatic Soft-tissue Sarcoma
Centre Leon Berard 47
Not applicableStudy completedNCT01763970
What this trial is testing

Stereotactic Radiation Therapy for Pediatric Sarcomas

Who this might be right for
SarcomaMetastatic DiseaseBony Sites
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 14
Testing effectiveness (Phase 2)Study completedNCT01900743
What this trial is testing

Phase II Study of Regorafenib in Metastatic Soft Tissue Sarcoma

Who this might be right for
Sarcoma
Centre Oscar Lambret 219
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Early research (Phase 1)WithdrawnNCT02210104
What this trial is testing

Adoptive Therapy Using Antigen-Specific CD4 T-Cells

Who this might be right for
MelanomaSarcoma
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT05301764
What this trial is testing

LVGN6051 Combined With Anlotinib in Patient With Soft Tissue Sarcoma

Who this might be right for
Soft Tissue Sarcoma
Lyvgen Biopharma Holdings Limited 39
Early research (Phase 1)Active Not RecruitingNCT05621668
What this trial is testing

A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Who this might be right for
Soft Tissue SarcomaBone Sarcoma
M.D. Anderson Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT03815474
What this trial is testing

Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma Patients

Who this might be right for
Sarcoma, Soft Tissue
Liaoning Cancer Hospital & Institute 47
Early research (Phase 1)Study completedNCT00006246
What this trial is testing

Busulfan in Treating Children and Adolescents With Refractory CNS Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorLeukemia+4 more
Pediatric Brain Tumor Consortium 28
Next Page